• Profile
Close

Lorazepam timing for acute convulsive seizure control (LoTASC)

Seizure - European Journal of Epilepsy Oct 09, 2020

Kamdar HA, Hamed M, Smetana KS, et al. - This retrospective study was undertaken to determine if administering lorazepam for convulsive seizures lasting less than 5 minutes causes vital instability. The sample consisted of patients who presented with a seizure lasting less than 5 minutes between 2011 and 2016. Continuous variables of lorazepam receivers vs non- receivers have been analyzed using t-test for parametric and Mann-Whitney U test for nonparametric data. Out of 1,052 participants initially screened, 165 were involved in the study. In patients who received lorazepam, there was a significantly greater incidence of vital instability (defined as receipt of a vasopressor or intubation), and this effect was dose-dependent. Lorazepam administration significantly lengthened the length of stay in the intensive care unit. Findings indicate that administration of lorazepam for acute convulsive seizures that do not meet the requirements for convulsive epileptic status can result in iatrogenic vital instability and ICU admission.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay